Aptose Biosciences
APTO
#10464
Rank
A$6.59 M
Marketcap
A$2.58
Share price
0.00%
Change (1 day)
726.43%
Change (1 year)

Earnings for Aptose Biosciences (APTO)

Earnings in 2025 (TTM): -A$31.68 Million

According to Aptose Biosciences's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$38.1 Million, an increase over its 2023 earnings that were of -A$79.08 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aptose Biosciences from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$31.68 Million-16.85%
2024 -A$38.1 Million-51.82%
2023 -A$79.08 Million22.9%
2022 -A$64.35 Million-34.91%
2021 -A$98.85 Million17.36%
2020 -A$84.23 Million107.65%
2019 -A$40.57 Million-7.73%
2018 -A$43.97 Million160.68%
2017 -A$16.87 Million-20.27%
2016 -A$21.16 Million28.71%
2015 -A$16.44 Million
2013 -A$9.32 Million
2010 -A$7.94 Million-8.31%
2009 -A$8.66 Million
2006 -A$16.05 Million-156.93%
2005 A$28.17 M-185.16%
2004 -A$33.09 Million458.58%
2003 -A$5.93 Million-63.66%
2002 -A$16.31 Million-8.04%
2001 -A$17.73 Million16.73%
2000 -A$15.19 Million294.99%
1999 -A$3.85 Million-6.51%
1998 -A$4.12 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Advaxis
ADXS
-A$51.39 Million 62.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Corbus Pharmaceuticals
CRBP
-A$86.96 Million 175.17%๐Ÿ‡บ๐Ÿ‡ธ USA
ImmunoGen
IMGN
-A$94.82 Million 200.06%๐Ÿ‡บ๐Ÿ‡ธ USA